3-195069939-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152531.5(XXYLT1):c.958G>A(p.Asp320Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000163 in 1,612,942 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152531.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XXYLT1 | NM_152531.5 | c.958G>A | p.Asp320Asn | missense_variant | 4/4 | ENST00000310380.11 | NP_689744.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XXYLT1 | ENST00000310380.11 | c.958G>A | p.Asp320Asn | missense_variant | 4/4 | 1 | NM_152531.5 | ENSP00000309640.6 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152214Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000354 AC: 88AN: 248272Hom.: 0 AF XY: 0.000282 AC XY: 38AN XY: 134824
GnomAD4 exome AF: 0.000162 AC: 236AN: 1460610Hom.: 1 Cov.: 32 AF XY: 0.000168 AC XY: 122AN XY: 726578
GnomAD4 genome AF: 0.000177 AC: 27AN: 152332Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2021 | The c.958G>A (p.D320N) alteration is located in exon 4 (coding exon 4) of the XXYLT1 gene. This alteration results from a G to A substitution at nucleotide position 958, causing the aspartic acid (D) at amino acid position 320 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at